The pooled analysis revealed a RR of 0.73 (95% CI 0.54–0.99), with a marginally significant p-value of 0.05 and low heterogeneity (I2 = 7%) (Fig. 5 ).
← all excerpts
Dapagliflozin in acute heart failure management: a systematic review and meta-analysis of safety and effectiveness.
1
—
—